Form 8-K - Current report:
SEC Accession No. 0001193125-26-294619
Filing Date
2026-07-02
Accepted
2026-07-02 16:21:14
Documents
9
Period of Report
2026-07-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20260701.htm   iXBRL 8-K 109693
  Complete submission text file 0001193125-26-294619.txt   219850

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT rkda-20260701.xsd EX-101.SCH 24852
12 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20260701_htm.xml XML 4672
Mailing Address 5956 SHERRY LANE SUITE 2000 DALLAS TX
Business Address 5956 SHERRY LANE SUITE 2000 DALLAS TX 214-974-8921
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 261151610
SIC: 1311 Crude Petroleum & Natural Gas
(CF Office: 01 Energy & Transportation)